USD
+0.00
(+0.00%
)AT CLOSE (AS OF Aug 13, 2025)
$137M
MARKET CAP
-
P/E Ratio
-2.1
EPS
$7.6
52 Week High
$3.4
52 Week Low
LIFE SCIENCES
Sector
Automate your trading workflow with powerful tools — built for serious traders.
Field | Value (CHF) |
---|---|
Gross Profit | -$43M |
Total Revenue | $5M |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$61M |
Selling General And Administrative | $17M |
Research And Development | $49M |
Operating Expenses | $66M |
Investment Income Net | - |
Net Interest Income | $3.3M |
Interest Income | $3.4M |
Interest Expense | $25K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.4M |
Income Before Tax | -$54M |
Income Tax Expense | $2K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$54M |
Comprehensive Income Net Of Tax | - |
Ebit | -$54M |
Ebitda | -$52M |
Net Income | -$54M |
Field | Value (CHF) |
---|---|
Total Assets | $159M |
Total Current Assets | $154M |
Cash And Cash Equivalents At Carrying Value | $64M |
Cash And Short Term Investments | $64M |
Inventory | - |
Current Net Receivables | $286K |
Total Non Current Assets | $4.2M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | $49K |
Intangible Assets Excluding Goodwill | $49K |
Goodwill | - |
Investments | - |
Long Term Investments | - |
Short Term Investments | $86M |
Other Current Assets | $4.6M |
Other Non Current Assets | - |
Total Liabilities | $17M |
Total Current Liabilities | $11M |
Current Accounts Payable | $679K |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $1.2M |
Total Non Current Liabilities | $6.1M |
Capital Lease Obligations | $2.4M |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $2.4M |
Other Current Liabilities | $8.9M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $142M |
Treasury Stock | - |
Retained Earnings | -$246M |
Common Stock | $4M |
Common Stock Shares Outstanding | $34M |
Field | Value (CHF) |
---|---|
Operating Cashflow | -$59M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $2.4M |
Capital Expenditures | $723K |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $40M |
Cashflow From Financing | $14M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | $0 |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$54M |
Field | Value (CHF) |
---|---|
Gross Profit | -$43M |
Total Revenue | $5M |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$61M |
Selling General And Administrative | $17M |
Research And Development | $49M |
Operating Expenses | $66M |
Investment Income Net | - |
Net Interest Income | $3.3M |
Interest Income | $3.4M |
Interest Expense | $25K |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $2.4M |
Income Before Tax | -$54M |
Income Tax Expense | $2K |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$54M |
Comprehensive Income Net Of Tax | - |
Ebit | -$54M |
Ebitda | -$52M |
Net Income | -$54M |
Sector: LIFE SCIENCES
Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Molecular Partners AG is a clinical-stage biopharmaceutical company. The company is headquartered in Schlieren, Switzerland.
Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.